Science Advances SJR and Scopus Metrics: What They Actually Mean
Science Advances still has a strong broad-scope citation profile, but the live submission question is whether your paper truly has cross-field consequence.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Science Advances at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 12.5 puts Science Advances in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~10% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Science Advances takes ~1-4 week. A faster-turnaround journal may suit a grant or job deadline better.
- If OA is required: gold OA costs $5,000. Check institutional agreements before submitting.
Quick answer: Science Advances still has a strong Scopus profile for a broad open-access journal. Current Scopus-based sources place it at SJR 4.324, impact score 12.06, global rank 367, and h-index 288 in 2024. That confirms real cross-field authority.
The useful submission question is whether the paper is genuinely broad and consequential enough for a multidisciplinary AAAS journal, not whether the venue still has metric legitimacy.
Direct answer
If your question is whether Science Advances still has strong Scopus standing, the answer is yes.
Metric | Current value | What it tells you |
|---|---|---|
SJR | 4.324 | prestige-weighted influence remains strong for a broad OA journal |
Impact Score | 12.06 | citation density is still high in current Scopus data |
Global rank | 367 | the journal remains comfortably above the broad middle tier |
h-index | 288 | the archive has already built real long-run reuse |
Best quartile | Q1 | the title remains top-tier in multidisciplinary classification |
Coverage history | 2015-2025 | this is established authority, not launch-phase noise |
That profile matters because Science Advances is no longer a new AAAS experiment. It is now a durable journal with its own citation identity.
Overview
The useful summary is that Science Advances sits in a high broad-journal tier below Science and Nature, but well above ordinary multidisciplinary overflow. That is exactly why authors misread it. It looks broad and open, but the breadth screen is still serious.
What changed in 2024
The 2024 picture is a softening year on SJR and a strengthening year on impact score.
- SJR moved down from 4.483 in 2023 to 4.324 in 2024
- impact score moved up from 11.18 to 12.06
- global rank moved from 347 to 367
That combination matters. The journal's articles were still cited heavily in 2024, but the prestige-weighted concentration of those citations softened a bit. For authors, that usually means the journal remains broadly influential while sitting slightly farther from the flagship end of the citation network than it did a few years ago.
Ten-year SJR and Scopus trend
Year | SJR | Impact Score | Global Rank |
|---|---|---|---|
2024 | 4.324 | 12.06 | 367 |
2023 | 4.483 | 11.18 | 347 |
2022 | 4.598 | 13.01 | 307 |
2021 | 4.586 | 13.98 | 316 |
2020 | 5.928 | 13.37 | 215 |
2019 | 6.062 | 13.56 | 201 |
2018 | 6.267 | 13.03 | 206 |
2017 | 5.817 | 12.28 | 228 |
2016 | 4.800 | 10.20 | 309 |
2015 | n/a | 0.00 | 33553 |
The trend shows a journal that climbed quickly, peaked in the late 2010s, and then settled into a still-strong but less inflated position. That is a healthier planning baseline for current authors than the launch-era excitement or the 2020 citation surge.
What the trend means in practice
For authors, the trend usually means:
- the journal still delivers real multidisciplinary visibility
- the broad OA model did not collapse the journal's authority
- near-fit papers are still risky because the journal can afford to screen hard
- the main decision variable is manuscript breadth, not journal legitimacy
That last point is the important one. You do not need to prove Science Advances is a real journal. You need to prove your paper belongs there.
How Science Advances compares with realistic neighbors
Journal | 2024 SJR | What the metric profile usually signals |
|---|---|---|
Nature | 18.288 | flagship multidisciplinary prestige concentration |
Science | 10.416 | elite general-science flagship with extreme breadth expectations |
Science Advances | 4.324 | strong broad OA journal with genuine cross-field authority |
PNAS | 3.414 | credible broad-science venue with softer prestige weighting |
This is the useful comparison. Science Advances is not in the Science or Nature tier, but it is also not just a brand-adjacent fallback. In 2024 it still outranks PNAS on SJR and keeps a stronger prestige-weighted profile than many authors assume.
What editors are really screening for
The journal's product is still broad consequence with open-access reach. In practice, that means editors are usually screening for:
- claims that matter outside one specialist lane
- evidence that feels complete enough for broad expert attention
- a story that can justify a large interdisciplinary readership
- work that is more than a strong niche paper wearing a broad-journal abstract
That is why the metrics remain strong. The journal is broad, but not easy.
What we see in Science Advances Metric Questions
For Science Advances metric questions, three mistakes recur.
The AAAS halo mistake. Authors often assume that because the journal is broad and open access, the editorial threshold must be softer than the metrics suggest. It is not.
The specialist-paper mistake. Another common miss is a technically strong paper with one-field consequence dressed up as multidisciplinary. The SJR does not rescue that mismatch.
The fallback mistake. We also see teams treat Science Advances as the automatic next stop after Science. That only works when the paper still has broad consequence in its own right.
That is the practical meaning of the current profile. The journal stays this strong because it still rejects a lot of good but too-bounded work.
What these metrics mean for authors
For authors, the current profile says:
- publication here still carries meaningful cross-field visibility
- the journal remains highly legible to committees that use Scopus-style evaluation
- accepted papers are expected to travel beyond one subfield
- if the paper really is broad, the upside is still substantial
The h-index of 288 matters because it reflects an archive that already has deep reuse despite being much younger than legacy flagship journals. That is evidence of durable authority, not only launch momentum.
Submit If / Think Twice If
Submit if:
- the main claim matters outside one narrow subfield
- the manuscript reads clearly to scientists beyond the core audience
- the evidence package feels finished rather than exploratory
- the story is genuinely broader than a strong specialty-journal paper
Think twice if:
- the paper depends heavily on local field context to feel important
- the work is broad in topic list but narrow in actual consequence
- the manuscript still has unresolved mechanistic or validation gaps
- the submission logic is being driven mostly by publisher brand
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
What should drive the decision after the metrics check
The better question is whether the manuscript is truly a Science Advances paper in its current form.
That is why the next useful reads are:
If the paper is broad and strong enough, the current metrics support the risk. If it is still fundamentally specialty-shaped, the metric profile is mostly warning you that the audience-fit mismatch will be expensive. A Science Advances submission framing check is a direct way to pressure-test that before submission.
Practical verdict
Science Advances still has a strong Scopus profile and remains a serious multidisciplinary target. The 2024 numbers are softer than the late-2010s peak, but not in any way that changes the basic submission logic.
For authors, the metric question is already answered. The live question is whether the manuscript is broad enough for the room.
- Science Advances JIF, Manusights.
Frequently asked questions
Science Advances' 2024 SJR is 4.324 on current Scopus-based metric aggregators, which keeps it in the upper tier of multidisciplinary journals.
Current Scopus-based sources place Science Advances' 2024 impact score at 12.06, with a global rank of 367 and h-index of 288.
Science is still far ahead on prestige-weighted concentration, while Science Advances remains stronger than PNAS on SJR in 2024 and operates as a broad open-access journal rather than a flagship weekly journal.
No. The real question is whether the manuscript has enough breadth and consequence for a serious multidisciplinary audience.
Sources
- 1. Science Advances metrics page, Resurchify.
- 2. Science Advances journal page, AAAS.
- 3. Science Advances information for authors, AAAS.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- How to Avoid Desk Rejection at Science Advances
- Is Science Advances a Good Journal? A Practical Fit Verdict for Authors
- Science Advances Under Evaluation: What the Status Usually Means
- Science Advances Response to Reviewers: How to Write a Rebuttal That Survives Cross-Disciplinary Re-Review (2026)
- Science Advances Pre-Submission Checklist: Is Your Paper Ready?
- Science Advances 'Under Review': What Each Status Means
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.